Page last updated: 2024-10-23

betahistine and Retinal Pigment Epithelial Detachment

betahistine has been researched along with Retinal Pigment Epithelial Detachment in 1 studies

Betahistine: A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
betahistine : An aminoalkylpyridine that is pyridine substituted by a 2-(methylamino)ethyl group at position 2. It acts as a histamine agonist and a vasodilator, and is thought to improve the microcirculation of the labyrinth, resulting in reduced endolymphatic pressure. It is used (generally as the hydrochloride or mesylate salt) to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hagler, WS1
Shacklett, DE1

Trials

1 trial available for betahistine and Retinal Pigment Epithelial Detachment

ArticleYear
Use of betahistine hydrochloride in postoperative retinal detachment patients.
    Annals of ophthalmology, 1971, Volume: 3, Issue:6

    Topics: Amine Oxidase (Copper-Containing); Betahistine; Choroid; Clinical Trials as Topic; Drug Eruptions; F

1971